Skip to content
★ Sign in to follow
CH

China Health Group Inc. Stock: price and insider trades · Hong Kong

HK·Mcap HK$78.6M

No insider purchase over the last 90 days. The latest, by GUO XIA, was filed 26 Mar 2021.

China Health Group Inc.: what insiders have been doing

Every trade that managers of China Health Group Inc. disclose to HKEX is tracked on this page. No insider at China Health Group Inc. has published a filing in the past twelve months. The most recent one dates from 5 August 2022.

Over the whole record (from 2017), the tally stands at 169 purchases and 3 sales.

For comparison within the same market, see the insider buying recorded at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. Source: insider filings from HKEX. Past trades are no guide to future returns.

Insider Decl.
174
Thresholds
n/a
Buy Volume
€904,272
169 ops. · all time
Sell Volume
n/a
3 ops. · all time

Since the insiders bought

  • Filed 31 Dec 2019 · 2505 days ago · €799
    +310.0%
    Entry HK$0.10 · Close at T+365 HK$0.41
  • Filed 11 Oct 2019 · 2586 days ago · €811
    +272.7%
    Entry HK$0.11 · Close at T+365 HK$0.41

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 18,782 of 26,913 companies
38.3
score / 100
Value
45
Quality
31
FCF yld9.6%
Earn yld-19%
EV/EBITDA·
ROE-20%
Gross mgn57%
Net mgn-52%
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$0.08
Analyst consensus
·
Income statement
RevenueHK$28.6M
Gross profitHK$16.4M57% margin
EBITDA-HK$14.4M-50% margin
Net income-HK$15M-47.4% margin
Valuation
P/Book1.0x
Beta-0.31
Balance sheet & cash
Market capHK$78.6M
Free Cash FlowHK$7.6M
Profitability & ownership
ROE-19.9%
ROA-8.5%
% insiders71.0%
% institutions0.0%
Last declaration on 5 August 2022
Declarations174 total
  • ●
    DirectorExecutives
    0HKEX
    960,000 sharesShareXHKGHKEX:DA20220805E00192
  • ●
    DirectorExecutives
    0HKEX
    960,000 sharesShareXHKGHKEX:DA20220804E00280
  • ▲
    DirectorExecutives
    0HKEX
    9,000,000 sharesShareXHKGHKEX:DA20210326E00303
    Canonical exit: 22 Jun 2021 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    100,000 sharesShareXHKGHKEX:DA20210326E00299
    Canonical exit: 22 Jun 2021 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    120,000 sharesShareXHKGHKEX:DA20210326E00297
    Canonical exit: 22 Jun 2021 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    160,000 sharesShareXHKGHKEX:DA20210326E00301
    Canonical exit: 22 Jun 2021 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    100,000 sharesShareXHKGHKEX:DA20210326E00295
    Canonical exit: 22 Jun 2021 (T+90)
  • ▲
    DirectorExecutives
    0HKEX
    100,000 sharesShareXHKGHKEX:DA20210326E00304
    Canonical exit: 22 Jun 2021 (T+90)
  • ▼
    DirectorExecutives
    0HKEX
    320,000 sharesShareXHKGHKEX:DA20201125E00047
  • ▼
    DirectorExecutives
    0HKEX
    200,000 sharesShareXHKGHKEX:DA20200526E00466
  • ▼
    DirectorExecutives
    0HKEX
    160,000 sharesShareXHKGHKEX:DA20200521E00366
  • ▲
    DirectorExecutives
    6,840 HKD23HKEX
    60,000 shares@ HK$0.1140.1% of flowShareXHKGHKEX:DA20191231E00271
    Canonical exit: 26 Dec 2019 (T+90)
  • ▲
    DirectorExecutives
    57,744 HKD11HKEX
    480,000 shares@ HK$0.12030.7% of flowShareXHKGHKEX:DA20191216E00199
    Canonical exit: 15 Mar 2020 (T+90)
  • ▲
    DirectorExecutives
    116,380 HKD11HKEX
    920,000 shares@ HK$0.12651.5% of flowShareXHKGHKEX:DA20191214E00029
    Canonical exit: 12 Mar 2020 (T+90)
  • ▲
    DirectorExecutives
    1,980 HKD11HKEX
    20,000 shares@ HK$0.0990.0% of flowShareXHKGHKEX:DA20191212E00424
    Canonical exit: 11 Mar 2020 (T+90)
  • ▲
    DirectorExecutives
    4,120 HKD11HKEX
    40,000 shares@ HK$0.1030.1% of flowShareXHKGHKEX:DA20191212E00415
    Canonical exit: 11 Mar 2020 (T+90)
  • ▲
    DirectorExecutives
    9,480 HKD11HKEX
    120,000 shares@ HK$0.0790.1% of flowShareXHKGHKEX:DA20191211E00298
    Canonical exit: 8 Mar 2020 (T+90)
  • ▲
    DirectorExecutives
    22,288 HKD11HKEX
    280,000 shares@ HK$0.07960.3% of flowShareXHKGHKEX:DA20191211E00301
    Canonical exit: 8 Mar 2020 (T+90)
  • ▲
    DirectorExecutives
    22,008 HKD11HKEX
    240,000 shares@ HK$0.09170.3% of flowShareXHKGHKEX:DA20191211E00311
    Canonical exit: 9 Mar 2020 (T+90)
  • ▲
    Related company / holdingExecutives
    7,002 HKD12HKEX
    60,000 shares@ HK$0.11675.4% of flowShareXHKGHKEX:DA20191011E00384
    Canonical exit: 9 Jan 2020 (T+90)
  • ▲
    Related company / holdingExecutives
    8,344 HKD12HKEX
    80,000 shares@ HK$0.10436.5% of flowShareXHKGHKEX:DA20191010E00350
    Canonical exit: 8 Jan 2020 (T+90)
  • ▲
    Related company / holdingExecutives
    11,300 HKD12HKEX
    100,000 shares@ HK$0.1138.8% of flowShareXHKGHKEX:DA20190919E00311
    Canonical exit: 17 Dec 2019 (T+90)
  • ▲
    Related company / holdingExecutives
    2,360 HKD11HKEX
    20,000 shares@ HK$0.1181.8% of flowShareXHKGHKEX:DA20190905E00364
    Canonical exit: 4 Dec 2019 (T+90)
  • ▲
    Related company / holdingExecutives
    42,912 HKD14HKEX
    240,000 shares@ HK$0.178832.5% of flowShareXHKGHKEX:DA20190613E00115
    Canonical exit: 10 Sept 2019 (T+90)
  • ▲
    Related company / holdingExecutives
    3,520 HKD11HKEX
    20,000 shares@ HK$0.1762.7% of flowShareXHKGHKEX:DA20190612E00038
    Canonical exit: 9 Sept 2019 (T+90)

25 of 174 declarations

About China Health Group Inc.

Recent ranked signals on the same market

Purchases our model currently ranks for the recommendations list.

All recommendations